CLINICAL EXPERIENCE WITH FIRST-LINE VRD IN PATIENTS DIAGNOSED WITH MULTIPLE MYELOMA

被引：0
|
作者：
De Miguel, Llorente Dunia [1 ]
Gil, Perez Angela [1 ]
Merchan, Munoz Beatriz [1 ]
Nuevo, Lopez Irene [1 ]
Perez, Ortega Alba [1 ]
Guillen, Garcia Helga [1 ]
Vazquez, Ramo Alejandro [1 ]
Subira, Perez Dolores [1 ]
Golbano, Lopez Nuria [1 ]
Santos, Montero Ana Belen [1 ]
Morales, Sanz Dolores [1 ]
Arbeteta, Juanis Jaime [1 ]
机构：
[1] Hosp Univ Guadalajara, Guadalajara, Spain
来源：
HAEMATOLOGICA | 2020年 / 105卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO-026
引用
收藏
页码：150 / 151
页数：2
相关论文
共 50 条
  • [41] First-Line Therapy of Multiple Myeloma requiring treatment Current Recommendations
    John, Lukas
    Goldschmidt, Hartmut
    Scheid, Christof
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2020, 145 (12) : 813 - 819
  • [42] Systematic Literature Review and Meta-Analysis of Comparative Clinical Evidence Investigating Daratumumab, Lenalidomide, and Dexamethasone (DRd) Versus Bortezomib, Lenalidomide, and Dexamethasone (VRd) As First-Line Treatment for Transplant-Ineligible Newly Diagnosed Multiple Myeloma
    Gordan, Lucio
    Medhekar, Rohan
    Fu, Alex Z.
    Ramirez, Abril Oliva
    Bonar, Nicolle
    Nguyen, Bao-Ngoc
    Spence, Michaela
    McTavish, Rebecca
    Disher, Tim
    Kaila, Shuchita
    Patel, Anjan J.
    BLOOD, 2023, 142
  • [43] First-line treatment with bortezomib, doxorubicine and dexamethasone followed by autologous peripheral blood stem cell transplantation in newly diagnosed patients with multiple myeloma
    Zinke-Cerwenka, W.
    Stojakovic, T.
    Rohn, A.
    Ziegler, I.
    Emberger, W.
    Sipurzynski, S.
    Linkesch, W.
    Neumeister, P.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S149 - S149
  • [44] Newly-Diagnosed, Non-Transplant Eligible Multiple Myeloma Patients: Determinants of Choice of First-Line Treatment in a Single-Center
    Paris, Laura
    Stefanoni, Paola
    Rambaldi, Alessandro
    Galli, Monica
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E235 - E236
  • [45] Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma
    Kristian T. Andersen
    Maja Hinge
    Agoston Gyula Szabo
    Erik Segel
    Tina Ormstrup
    Paw C. Holdgaard
    Niels Pallisgaard
    Gitte Kerndrup
    Torben Plesner
    Clinical Hematology International, 2020, 2 (1) : 35 - 39
  • [46] Skeletal survey reported by experienced radiologist remains adequate as first-line radiological test for the majority of newly-diagnosed patients with multiple myeloma
    Moghul, S.
    Fisher, A. E.
    Liapis, K.
    Theodoulou, A.
    Cavenagh, J.
    Oakervee, H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 : 55 - 56
  • [47] REAL EXPERIENCE OF TREATMENT WITH DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA IN THE FIRST LINE AND IN RECALL/REFRACTORY
    Fernandez, Moreno F.
    Sole, Rodriguez M.
    Dominguez, Rodriguez J. F.
    HAEMATOLOGICA, 2020, 105 : 367 - 367
  • [48] Machine learning-assisted identification of optimal first-line treatment for newly diagnosed, transplant ineligible multiple myeloma
    Koo, Jamin
    Park, Sung-Soo
    Min, Chang-Ki
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S146 - S146
  • [49] Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myeloma
    Yamamoto, Chihiro
    Minakata, Daisuke
    Koyama, Shunsuke
    Sekiguchi, Kaoru
    Fukui, Yuta
    Murahashi, Rui
    Nakashima, Hirotomo
    Matsuoka, Sae
    Ikeda, Takashi
    Kawaguchi, Shin-ichiro
    Toda, Yumiko
    Ito, Shoko
    Nagayama, Takashi
    Umino, Kento
    Nakano, Hirofumi
    Morita, Kaoru
    Yamasaki, Ryoko
    Ashizawa, Masahiro
    Ueda, Masuzu
    Hatano, Kaoru
    Sato, Kazuya
    Ohmine, Ken
    Fujiwara, Shin-ichiro
    Kanda, Yoshinobu
    BLOOD, 2022, 140 (06) : 594 - 607
  • [50] Bortezomib, Lenalidomide and Dexamethasone (VRD) Followed By Autologous Stem Cell Transplant for Newly Diagnosed Multiple Myeloma; The Mayo Clinic Experience
    Sidiqi, M. Hasib
    Aljama, Mohammed A.
    Dispenzieri, Angela
    Muchtar, Eli
    Buadi, Francis K.
    Warsame, Rahma
    Lacy, Martha Q.
    Dingli, David
    Leung, Nelson
    Gonsalves, Wilson I.
    Kapoor, Prashant
    Kourelis, Taxiarchis
    Hogan, William J.
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    Gertz, Morie A.
    BLOOD, 2018, 132
12345